MIRD pamphlet no. 17: The dosimetry of nonuniform activity distributions - Radionuclide S values at the voxel level

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages

  Bolch, Wesley E ^a   Bouchet, Lionel G ^b   Robertson, James S ^b   Wessels, Barry W ^b   Siegel, Jeffry A ^b   Howell, Roger W ^b   Erdi, Alev K ^b   Aydogan, Bulent ^b   Costes, Sylvain ^b   Watson, Evelyn E ^b   Brill, A B ^b   Charkes, N D ^b   Fisher, D R ^b   Hays, M T ^b   Thomas, S R ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE

Author keywords

Dosimetry; MIRD schema; Nonuniform; Radionuclide; Voxel S values

Indexed keywords

RADIOISOTOPE;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RADIOACTIVITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032898060     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Loevinger R, Budinger TF, Watson EE. MIRD Primer fur Absorbed Dose Calculations. Revised. New York: The Society of Nuclear Medicine; 1991.
2. Snyder WS, Ford MR, Warner GG, Watson SB. "S," absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No 11. New York: Society of Nuclear Medicine; 1975.
3. Snyder WS, Ford MR, Warner GG. Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom, MIRD Pamphlet No 5 Revised. New York: Society of Nuclear Medicine: 1978.
4. Howell RW, Loevinger R. The MIRD Perspective. J Nucl Med 1998;40.
5. ICRP. Report on the Task Group on Reference Man, ICRP Publ. No. 23. International Commission on Radiological Protection; Oxford, 1975.
6. Siegel JA, Thomas SR, Stubbs JB, et al. MIRD Pamphlet No. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 1998;40. February.
7. Saha GB, MacIntyre WJ, Go RT. Radiopharmaceuticals for brain imaging. Semin Nucl Med 1994;24:324-349.
8. Messa C, Fazio F, Costa DC, Ell PJ. Clinical brain radionuclide imaging studies. Semin Nucl Med 1995;25:111-143.
9. van Heertum RL, Tikofsky RS. Cerebral SPECT imaging, 2nd ed. New York: Raven Press; 1995.
10. Bouchet LG, Bolch WE, Weber DA, Atkins HL, Poston JW. MIRD Pamphlet No. 15: radionuclide S values in a revised dosimetric model of the adult head and brain. J Nucl Med 1998;40. March.
11. Coffey JL, Watson EE. S-values for selected radionuclides and organs with the heart wall and heart contents as source organs. In: Watson EE, Schlafke-Stelson AT, Coffey JL, Cloutier RJ, eds. Third international radiopharmaceutical dosimetry: symposium, FDA 81-8166. Rockville, MD: United States Department of Health & Human Services; 1981:563-594.
12. Coffey JL, Cristy M, Warner GG. MIRD Pamphlet No. 13: specific absorbed fractions for photon sources uniformly distributed in the heart chambers and heart wall of a heterogeneous phantom. J Nucl Med 1981;22:65-71.
13. Blanco P, Bouchet LG Rajon D, Bolch WE. Considerations of suborgan dosimetry within the 1997 versions of the MIRD mathematical phantoms. In: Gieger D, Aletti P, eds. World congress on medical physics and biomedical engineering. Nice, France: International Federation for Medical & Biological Engineering; 1997:1118.
14. Bolch WE, Blanco P, Bouchel LG. Electron absorbed fractions for use under the MIRD schema within the ORNL mathematical models of pediatric patients. J Nucl Med 1997;38:225P.
15. McAfee JG. Problems in evaluating the radiation dose for radionuclides excreted by the kidneys. In: Cloutier RJ, Edwards CL, Snyder WS, eds. Medical radionuclides: radiation dose and effects. Oak Ridge, TN: United States Atomic Energy Commission; 1969:271-294.
16. Humm JL. Dosimctric aspects of radiolabeled antibodies for tumor therapy. J Nucl Med 1986;27:1490-1497.
17. Humm JL, Cobb LM. Nonuniformity of tumor dose in radioimmunotherapy. J. Nucl Med 1990;31:75-83.
18. Howell RW, Rao DV, Sastry KSR. Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors. Med Phys 1989;16:66-74.
19. Yorke ED, Williams LE, Demidecki AJ, Heidorn DB, Roberson PL, Wessels BW. Multicellular dosimetry for beta-emitting radionuclides: autoradiography, thermoluminescent dosimetry and three-dimensional dose calculations. Med Phys 1993;20: 543-550.
20. Eckerman KF, Ryman JC, Taner AC, Kerr GD. Traversal of cells by radiation and absorbed fraction estimates for electrons and alpha particles. In: Schlafke-Stelson AT, Watson EE, eds. Proceedings of the fourth international radiopharmaceutical dosimetry symposium. CONF-851113. Oak Ridge, TN: Oak Ridge Associated Universities; 1985:67-81.
21. Fisher DR. The microdosimetry of monoclonal antibodies labeled with alpha emitters. In: Schlafke-Stelson AT, Watson EE, eds. Proceedings of the fourth international radiopharmaceutical dosimetry symposium, CONF-851113 (DE86010102). Springfield, VA: National Technical Information Service: 1986:26-36.
22. Sastry KSR, Haydock C, Basha AM, Rao DV. Electron dosimetry for radioimmunotherapy: optimal electron energy. Radiat Prot Dosim 1985;13:249-252.
23. Tisljar-Lentulis G, Feinendegen LE, Walther H. Calculation of specific energies of incorporated Pu-239 and I-131 in accordance with the concept of the critical cell. Radiat Envir Biophys 1976;13:197-204.
24. Makrigiorgos GM, Adelstein SJ, Kassis AI. Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium-99m-labeled microspheres and macroaggregates. JAMA 1990;264:592-595.
25. Makrigiorgos GM, Adelstein SJ, Kassis AI. Limitations of conventional internal dosimetry at the cellular level. J Nucl Med 1989;30:1856-1864.
26. Humm JL, Chin LM. Cellular dosimetry. In: Adelstein SJ, Kassis AI, Burt RW, eds. Dosimetry of administered radionuclides. Washington, DC: American College of Nuclear Physicians; 1990:306-330.
27. Sastry KSR, Rao DV. Dosimetry of low energy electrons. In: Rao DV, Chandra R, Graham M, eds. Physics of nuclear medicine: recent advances. New York: American Institute of Physics; 1984:169-208.
28. Gardin I, Linhart NC, Petiet A, Bok B. Dosimetry at the cellular level of Kupffer cells after technetium-99m-sulfur colloid injection. J Nucl Med. 1992;33:380-384.
29. Gardin I, Faraggi M, Huc E, Bok BD. Modelling of the relationship between cell dimensions and mean electron dose delivered to the cell nucleus: application to five radionuclides used in nuclear medicine. Phys Med Biol 1995;40:1001-1014.
30. Goddu SM, Rao DV, Howell RW. Multiceliular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J Nucl Med 1994;35:521-530.
31. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. MIRD cellular S values: self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Reston, VA: Society of Nuclear Medicine; 1997.
32. 131I-labeled antibodies in follicular lymphoma. Med Phys 1992;19:97-104.
33. Fourre C, AP, Colas-Linhart M. Mutual contribution by "track" microautoradiography method (MRA) and secondary ion mass spectrometry (SIMS) microscopy: prospects in technetium dosimetry at the cellular level. Cell Mol Biol 1996;42:385-393.
34. Howell RW. The MIRD schema: from organ to cellular dimensions. J Nucl Med 1994;35:531-533.
35. Glass WA, Varma MN. Physical and chemical mechanisms in molecular radiation biology. Basic Life Sciences No. 58. New York: Plenum Press; 1991.
36. Varma MN, Chatterjee A. Computational approaches in molecular radiation biology. Basic Life Sciences 63. New York: Plenum Press; 1994.
37. Fielden EM, O'Neill P. The early effects of radiation on DNA. NATO ASI Series H: Cell Biology 54. New York: Springer-Verlag; 1991.
38. Fuciarelli AF, Zimbrick JD. Radiation damage to DNA: structure/function relationships at early times. Richland: Battelle Press; 1995.
39. Sgouros G, Barest G, Thekkumthala J, et al. Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. J. Nucl Med 1990;31:1884-1891.
40. Sgouros G, Chiu S, Pentlow KS, et al. Three-dimensional dosimetry for radioimmunotherapy treatment planning. J Nucl Med 1993;34:1595-1601.
41. Zanzonico PB, Bigler RE, Sgouros G, Strauss A. Quantitative SPECT in radiation dosimetry. Semin Nucl Med 1989;19:47-61.
42. Macey DJ, Giap HB. Quantitative SPECT. In: Kramer EL, Sanger JJ, eds. Clinical SPECT imaging. New York: Raven Press, Ltd.; 1995:69-78.
43. Leichner PK, Koral KF, Jaszczak RJ, Green AJ, Chen GTY, Roeske JC. An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy. Med Phys 1993;20:569-577.
44. King MA, Long DT, Brill AB. SPECT volume quantitation: influence of spatial resolution, source size and shape, and voxel size. Med Phys 1991;18:1016-1024.
45. Giap HB, Macey DJ, Podoloff DA. Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy. J Nucl Med 1995;36: 1885-1894.
46. Yorke ED, Williams LE, Demidecki AJ, Heidorn DB, Roberson PL, Wessels BW. Multicellular dosimetry for beta-emitting radionuclides: autoradiography, thermoluminescent dosimetry, and three-dimensional dose calculations. Med Phys 1993;20: 543-550.
47. Erdi AK, Yorke ED, Loew MH, Erdi YE, Sarfaraz M, Wessels BW. Use of the fast hartley transform for three-dimensional dose calculation in radionuclide therapy. Med Phys 1998;11:2226-2233.
48. Furhang EE, Chui CS, Sgouros G. A Monte Carlo approach to patient-specific dosimetry. Med Phys 1996;23:1523-1529.
49. Bolch WE, Bouchet LG, Aydogan B, Wessels BW, Siegel JA. Voxel S values for use in dosimetry for nonuniform activity distributions In: Gieger D, Aletti O, eds. World congress on medical physics and biomedical engineering. Nice, France: International Federation of Medical and Biological Engineering; 1997:861.
50. Bolch WE, Costes S, Bouchet LG, Wessels BW, Siegel JA. Roberston JS. Cubical S values for the rapid assessment of suborgan dosimetry of nonuniform activity distributions. In: Schlafke-Stelson AT, ed. Proceedings of the sixth international radiopharmaceutical dosimetry symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1999: in press.
51. Akahani G, Hawkins WG, Eckblade MB, Leichner PK. Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete fourier transform convolution. J Nucl Med 1997;38:308-314.
52. Liu A, Williams LE, Wong JYC, Raubitschek AA. A voxel source kernel (VSK) method for rapid, patient-specific dose estimates in radioimmunotherapy (RIT). J Nucl Med 1997;38(suppl):106P.
53. Spencer LV. Theory of electron penetration. Phys Rev 1955;98:1597-1615.
54. Spencer LV. Energy dissipation by fast electrons, Monograph No. 1. National Bureau of Standards. Gaithersburg, MD; 1959.
55. Cross WG. Tables of beta dose distributions. Report No. AECL-2793. Atomic Energy of Canada Ltd. Chalk River, Ontario; 1967.
56. Berger MJ. Distribution of absorbed dose around point sources of electrons and beta particles in Hater and other media. MIRD Pamphlet No. 7. New York: Society of Nuclear Medicine; 1971.
57. Cross WG, Ing H, Freedman NO, Mainville J. Tables of beta-ray distributions in water, air, and other media, Report No. AECL-7617. Atomic Energy of Canada Ltd; 1982.
58. Loevinger R, Japha EM, Brownell GL. Discrete radioisotope sources. In: Hine GJ, Brownell GL, eds. Radiation dosimetry. New York: Academic Press; 1956:693-755.
59. Bochkarev VV, Radzievsky GB, Timofeev LV, Demianov NA. Distribution of absorbed energy from a point beta-source in a tissue-equivalent medium. Int J Appl Radiat Isotopes 1972;23:493-504.
60. Vynckier S, Wambersie A. Dosimetry of beta sources in radiotherapy. I. The beta point source dose function. Phys Med Biol 1982;27:1339-1347.
61. Chabot GE, Skrable KW, French CS. When hot particles are not on the skin. Radiat Prot Manag 1988;5:31-42.
62. Prestwich WV, Nunes J, Kwok CS. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. J Nucl Med 1989;30:1036-1046.
63. Leichner PK, Hawkins WG, Yang N. A generalized, empirical point-source function for beta-particle dosimetry. Antibody Immunoconj Radiopharm 1989;2:125-144.
64. Cross WG. Empirical expressions for beta ray point source dose distributions. Radiat Prot Dosim 1997;69:85-96.
65. Cross WG. The distribution of absorbed energy from a beta point source. Can J Phys 1967;45:2021-2040.
66. Cross WG. Distribution of absorbed beta energy in solid media. Can J Phys 1969;47:75-83.
67. Seltzer SM. An overview of ETRAN Monte Carlo methods. In: Jenkins TM, Nelson WR, Rindi A, eds. Monte Carlo transport of electrons and photons. New York: Plenum Press; 1988:153-181.
68. Berder MJ, Monte Carlo calculation of the penetration and diffusion of fast charged particles. In: Alder B, Fernbach S, Rotenberg M, eds. Methods in computational physic. Vol. I. New York: Academic Press; 1963.
69. Berber MJ. Improved point kernels for electron and beta-ray dosimetry. NBSIR-73-107. National Bureau of Standards. Gaithersburg, MD: 1973.
70. Berger MJ. Electron stopping powers for transport calculations. In: Jenkins TM, Nelson WR, Rindi A, eds. Monte Carlo transport of electrons and photons. New York: Plenum Press; 1988:183-219.
71. Seltzer SM. Cross sections for bremsstrahlung production and electron-impact ionization In: Jenkins TM, Nelson WR, Rindi A, eds. Monte Carlo transport of electrons and photons. New York: Plenum Press; 1988:81-114.
72. Rogers DWO, Bielajew AF. A comparison of EGS4 and ETRAN. In: Jenkins TM, Nelson WR, Rindi A, eds. Monte Carlo transport of electrons and photons. New York: Plenum Press; 1998:323-344.
73. Rogers DWO, Bielajew AF. Differences in electron depth dose curves calculated with EGS and ETRAN and improved energy-range relationships. Med Phys 1986;13:687-644.
74. Seltzer SM. Electron-photon Monte Carlo calculations: the ETRAN code. Appl Radiat Isot 1991;42:917-941.
75. Simpkin DJ, Mackie TR. EGS4 Monte Carlo determination of the beta dose kernel in water. Med Phys 1990;17:174-186.
76. Cross WG, Freedman NO, Wong PY. Beta-ray dose distributions from point sources in an infinite water medium. Health Phys 1992;63:160-171.
77. Cross WG, Freedman NO, Wong PY. Tables of beta-ray dose distributions in water. AECL Report 10521. Chalk River, Ontario: Atomic Energy of Canada, Ltd; 1992.
78. Berger MJ. Energy deposition in water by photons from point isotropic sources. MIRD Pamphlet No 2. New York: Society of Nuclear Medicine; 1968.
79. Spencer LV, Fano U. J Res Nucll Bureau Stand 1951;46:446.
80. Kwok CS, Prestwieh WV, Wilson BC. Calculation of radiation doses for nonuniformly distributed beta and gamma radionuclides in soft tissue. Med Phys 1985;12: 405-412.
81. Leichner PK. A unified approach to photon and beta particle dosimetry. J Nucl Med 1994;35:1721-1729.
82. Furhang EE, Sgouros G, Chui CS. Radionuclide photon dose kernels for internal emitter dosimetry. Med Phys 1996;23:759-764.
83. Erdi AK, Loew M, Yorke ED, Wessels BW. Use of the fast Hartley transform for efficient 3D convolution in calculations of radiation dose. In: Proceedings of the sixteenth annual IEEE-EMBS conference. Baltimore, MD: 1994:639-640.
84. Kwok CS, Irfan M, Woo MK, Prestwieh WV. Effect of tissue inhomogeneity on beta dose distribution of P-32. Med Phys 1987;14:98-104.
85. Berger MJ. Beta-ray dosimetry calculations with the use of point kernels. In: Cloutier RJ, Edwards CL, Snyder WS, eds. Radiation dose and effects. Washington, DC: United States Atomic Energy Commission: 1970:63-86.
86. Faw RE, Shultis JK. Electron penetration and dose evaluation. In: Radiological assessment sources and exposures. Englewood Cliffs, NJ: PTR Prentice-Hall; 1993:322-372.
87. Kolbert KS, Sgouros G, Scott AM, et al. Implementation and evaluation of patient-specific three-dimensional internal dosimetry. J Nucl Med 1997;38:301-308.
88. Roberson PL, Heidorn DB, Kessler ML, Ten Haken RK, Buchsbaum DJ. Three-dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of best dose-rate nonuniformity. Cancer 1994;73:912-918.
89. Erdi AK, Wessels BW, DeJager R, et al. Tumor activity confirmation and isodose curve display for patients receiving iodine-131-labelled 16.88 human monoclonal antibody. Cancer 1994;73:932-944.
90. Leichner PK, Kwok CS. Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles. Med Phys 1993;20:529-534.
91. Erdi AK, Erdi YE, Yorke ED, Wessels BW. Treatment planning for radioimmunotherapy. Phys Med Biol 1996;41:2009-2026.
92. Jenkins TM, Nelson WM, Rindi A. Monte Carlo transport of electrons and photons, International Science Series 38. New York: Plenum Press; 1988.
93. Tagesson M, Ljungberg M, Strand SE. The SIMDOS Monte Carlo code for the conversion of activity distributions to absorbed dose and dose rate distributions. In: Schlafke-Stelson AT, ed. Proceedings of the sixth international radiopharmaceutical dosimetry symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1999: in press.
94. Johnson TK. MABDOSE: A generalized program for internal radionuclide dosimetry. Comput Methods Progr Biomed 1988;27:159-167.
95. Johnson TK, McClure DL, McCourt SL, Andl GJ, Berman BD. MABDOSE. A computer program for the calculation of dose. In: Schlafke-Stelson AT, ed. Proceedings of the sixth international radiopharmaceutical dosimetry syposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1499: in press.
96. Meredith RF, Johnson TK, Plott G, et al. Dosimetry of solid tumors. Med Phys 1993;20:583-592.
97. Bielajew AF, Rogers DWO. Electron step-size artifacts and PRESTA. In: Jenkins TM, Nelson WR, Rindi A, eds. Monte Carlo transport electrons and photons. New York: Plenum Press; 1988:115-138.
98. Bielajew AF, Rogers DWO. PRESTA, the parameter reduced electron step transport algorithm for electron Monte Carlo transport. Nucl Instr Meth 1987;B18:165-181.
99. Cristy M, Eckerman KF. Specific absorbed fractions of enegy at various ages from internal photon sources. ORNL/TM-8381/Vols. I VII. Oak Ridge, TN: Oak Ridge National Laboratory; 1987.
100. Eckerman KF, Westfall RJ, Ryman JC, Cristy M. Availability of nuclear decay data in electronic form, including beta spectra not previously published. Health Phys 1994;67:338-345.
101. Eckerman KF, Westfall RJ, Ryman JC, Cristy M. Nuclear decay data files of UK dosimetry research group, ORNL/TM-12350. Oak Ridge, TN: Oak Ridge National Laboratory; 1993.
102. Loevinger R, Berman M. A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MIRD Pamphlet No. 1 Revised. New York: Society of Nuclear Medicine: 1976.
103. Siegel JA. Quantitative bremsstrahlung SPECT imaging: attenuation-corrected activity determination. J Nucl Med 1994;35:1213-1216.
104. Siegel JA, Zeiger LS, Order SE, Wallner PE. Quantitative bremsstrahlung single photon emission computed tomographic imaging: use for volume, activity, and absorbed dose calculations. Int J Radiat Oncol Biol Phys 1995;31:953-958.
105. Parsai EI, Ayyangar KM, Dobelbower RR, Siegel JA. Clinical fusion of three-dimensional images using bremsstrahlung SPECT and CT. J. Nucl Med 1997;38:319-324.
106. Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med 1988;29:1795-1809.
107. 131I-labeled antibody. Med Phys 1992;19:1213-1218.
108. Holmes TW, Mackie TR, Reckwerdt P. An iterative filtered backprojection inverse treatment planning algorithm for tomotherapy. Int J Radiat Oncol Biol Phys 1995;32:1215-1225.
109. Goitein M. Causes and consequences of inhomogeneous dose distributions in radiation therapy. Int J Radiat Oncol Biol Phys 1986;12:701-704.
110. Whithers HR, Taylor JMG, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988;14:751-759.
111. Johns HE, Cunningham JR. The physics of radiology, 4th ed. Springfield, IL: Charles C. Thomas Publishers; 1983.
112. Drzymala RE, Mohan R, Brewster L. Dose-volume histograms. Int J Radiat Oncol Biol Phys 1991;21:71-78.
113. Emami B, Lyman J, Brown A. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
114. Vijayakumar S, Chen GTY. Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges. Int J Radiat Oncol Biol Phys 1995;33:979-983.
115. Sailer SL, Chaney EL, Rosenman JG, Sherouse GW, Tepper JE. Treatment planning at the University of North Carolina at Chapel Hill. Semin Radiat Oncol 1992;2:267-273.
116. Leibel SA, Kutcher GJ, Mohan R. Three-dimensional conformal radiation therapy at the Memorial Sloan-Kettering Cancer Center. Semin Radiat Oncol 1992;2:274-289.
117. Lawrence TS, Ten H, Randall K, Kessler ML. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992;23:781-788.
118. Roberson PL, Ten Haken RK, McShan DL, McKeever PE, Ensminger WD. Three-dimensional tumor dosimetry for hepatic Y-90 microsphere therapy. J Nucl Med 1992;33:735-738.
119. Press OW, Eary JF, Appelbaum FR. Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;329:1219-1224.
120. Suit H, DuBois W. The importance of optimal treatment planning in radiation therapy. Int J Radiat Oncol Biol Phys 1991;21:1471-1478.